Chevy Chase Trust Holdings LLC Sells 1,373 Shares of Humana Inc. (NYSE:HUM)

Chevy Chase Trust Holdings LLC lowered its holdings in shares of Humana Inc. (NYSE:HUM - Free Report) by 2.1% during the 4th quarter, according to the company in its most recent filing with the SEC. The fund owned 64,005 shares of the insurance provider's stock after selling 1,373 shares during the period. Chevy Chase Trust Holdings LLC owned about 0.05% of Humana worth $16,239,000 as of its most recent filing with the SEC.

Several other institutional investors and hedge funds also recently made changes to their positions in the business. Creative Financial Designs Inc. ADV boosted its position in Humana by 244.0% during the 3rd quarter. Creative Financial Designs Inc. ADV now owns 86 shares of the insurance provider's stock valued at $27,000 after buying an additional 61 shares during the period. Ashton Thomas Securities LLC purchased a new stake in Humana during the 3rd quarter valued at $31,000. Your Advocates Ltd. LLP lifted its position in shares of Humana by 81.8% in the 3rd quarter. Your Advocates Ltd. LLP now owns 100 shares of the insurance provider's stock worth $32,000 after purchasing an additional 45 shares during the period. Atwood & Palmer Inc. lifted its position in shares of Humana by 64.5% in the 4th quarter. Atwood & Palmer Inc. now owns 153 shares of the insurance provider's stock worth $39,000 after purchasing an additional 60 shares during the period. Finally, LRI Investments LLC lifted its position in shares of Humana by 1,021.4% in the 3rd quarter. LRI Investments LLC now owns 157 shares of the insurance provider's stock worth $50,000 after purchasing an additional 143 shares during the period. Institutional investors own 92.38% of the company's stock.

Humana Stock Performance

NYSE HUM traded up $8.30 during trading hours on Wednesday, hitting $265.54. 1,222,369 shares of the company's stock traded hands, compared to its average volume of 1,691,672. The business's fifty day moving average price is $270.05 and its two-hundred day moving average price is $291.47. The company has a current ratio of 1.76, a quick ratio of 1.76 and a debt-to-equity ratio of 0.68. The firm has a market capitalization of $31.97 billion, a P/E ratio of 26.69, a P/E/G ratio of 1.91 and a beta of 0.56. Humana Inc. has a 52 week low of $213.31 and a 52 week high of $406.46.

Humana (NYSE:HUM - Get Free Report) last announced its earnings results on Tuesday, February 11th. The insurance provider reported ($2.16) earnings per share (EPS) for the quarter, beating the consensus estimate of ($2.26) by $0.10. Humana had a net margin of 1.02% and a return on equity of 11.70%. Equities research analysts predict that Humana Inc. will post 16.49 EPS for the current year.

Insider Buying and Selling at Humana

In other Humana news, insider Timothy S. Huval sold 3,703 shares of the business's stock in a transaction on Tuesday, December 31st. The shares were sold at an average price of $256.26, for a total transaction of $948,930.78. Following the transaction, the insider now owns 8,181 shares in the company, valued at $2,096,463.06. The trade was a 31.16 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available at this link. Insiders own 0.29% of the company's stock.

Wall Street Analysts Forecast Growth

HUM has been the subject of several research analyst reports. Wells Fargo & Company dropped their target price on shares of Humana from $387.00 to $290.00 and set an "overweight" rating for the company in a research report on Monday, November 4th. Barclays lifted their price target on shares of Humana from $255.00 to $270.00 and gave the company an "equal weight" rating in a research report on Thursday, February 13th. Piper Sandler lifted their price target on shares of Humana from $270.00 to $288.00 and gave the company a "neutral" rating in a research report on Wednesday, January 15th. Cantor Fitzgerald reissued a "neutral" rating and set a $290.00 price target on shares of Humana in a research report on Wednesday, February 12th. Finally, TD Cowen lifted their price target on shares of Humana from $261.00 to $268.00 and gave the company a "hold" rating in a research report on Monday, November 4th. Nineteen equities research analysts have rated the stock with a hold rating and five have given a buy rating to the stock. According to MarketBeat.com, Humana has an average rating of "Hold" and a consensus price target of $285.68.

About Humana

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.